The harmful effects of Aflatoxin B1 (AFB1) are a consequence of it being metabolized to AFB1-8,9-epoxide, a compound that serves as an alkylating agent and mutagen. The toxicity of AFB1 towards different cells varies substantially; sensitivity can change significantly during development, can be modulated by treatment with xenobiotics and is decreased markedly in preneoplastic lesions as well as in tumors. Three types of resistance, namely intrinsic, inducible and acquired, can be identified. The potential resistance mechanisms include low capacity to form AFB1-8,9-epoxide, high detoxification activity, increase in AFB1 efflux from cells and high DNA repair capacity. Circumstantial evidence exists that amongst these mechanisms the glutathion...
Ingestion of aflatoxin B1 (AFB1) represents a major risk factor in the aetiology of human hepatocell...
The mycotoxin aflatoxin B 1 (AFB 1 ) is a hepatocarcinogen in many animal models and probably a huma...
The potent liver carcinogen aflatoxin B1 (AFB1) is metabolized by cytochrome P450 to the mutagenic e...
The harmful effects of Aflatoxin B1 (AFB1) are a consequence of it being metabolized to AFB1-8,9-epo...
The toxicity of aflatoxin B1 (AFB1), has been extensively studied in the rat, and its carcinogenic e...
A number of xenobiotics, including the synthetic antioxidant ethoxyquin, inhibit aflatoxin B1 (AFB1)...
The rat can be protected against aflatoxin B1 (AFB1) hepatocarcinogenesis by being fed on a diet con...
<p class="MsoNormal"><span style="font-size: 10pt; font-family: QuorumITCbyBT-Book">Afla...
Fischer 344 rats readily develop liver cancer when exposed to aflatoxin B1 (AFB1) but dietary admini...
Glutathione-S-transferase-catalyzed conjugation of glutathione (GSH) to aflatoxin B1-8,9-epoxide pla...
A purification scheme has been devised for two ethoxyquin-inducible Alpha-class glutathione S-transf...
In both experimental animals and humans, aflatoxin B1 (AFB1) is a potent hepatic toxin and carcinoge...
Ingestion of aflatoxin B1 (AFB1) represents a major risk factor in the aetiology of human hepatocell...
The mycotoxin aflatoxin B 1 (AFB 1 ) is a hepatocarcinogen in many animal models and probably a huma...
The potent liver carcinogen aflatoxin B1 (AFB1) is metabolized by cytochrome P450 to the mutagenic e...
The harmful effects of Aflatoxin B1 (AFB1) are a consequence of it being metabolized to AFB1-8,9-epo...
The toxicity of aflatoxin B1 (AFB1), has been extensively studied in the rat, and its carcinogenic e...
A number of xenobiotics, including the synthetic antioxidant ethoxyquin, inhibit aflatoxin B1 (AFB1)...
The rat can be protected against aflatoxin B1 (AFB1) hepatocarcinogenesis by being fed on a diet con...
<p class="MsoNormal"><span style="font-size: 10pt; font-family: QuorumITCbyBT-Book">Afla...
Fischer 344 rats readily develop liver cancer when exposed to aflatoxin B1 (AFB1) but dietary admini...
Glutathione-S-transferase-catalyzed conjugation of glutathione (GSH) to aflatoxin B1-8,9-epoxide pla...
A purification scheme has been devised for two ethoxyquin-inducible Alpha-class glutathione S-transf...
In both experimental animals and humans, aflatoxin B1 (AFB1) is a potent hepatic toxin and carcinoge...
Ingestion of aflatoxin B1 (AFB1) represents a major risk factor in the aetiology of human hepatocell...
The mycotoxin aflatoxin B 1 (AFB 1 ) is a hepatocarcinogen in many animal models and probably a huma...
The potent liver carcinogen aflatoxin B1 (AFB1) is metabolized by cytochrome P450 to the mutagenic e...